EPO Patents = 6

Forward Citations = 17

Loading Chart...

5 inventors (with patents filed for the assignee):

Kostantinos (Kostas) Kosmatopoulos (4 out of 5 patents)

Jeanne Menez-Jamet (3 out of 5 patents)

Stéphanie Graff-Dubois (1 out of 3 patents)

4. Kostantinos Kosmatopoulos (1 out of 1 patent)

5. Sébastien Cornet (1 out of 1 patent)

6. Catherine Gallou (0 patent)

5 patents: Sort by Forward Citations

1. 10024868 - Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy (2018-07-17),

2. 8900600 - Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy (2014-12-02),

3. 8663645 - Use of native peptides and their optimized derivatives for vaccination (2014-03-04),

4. 8465747 - Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy (2013-06-18),

5. 7973128 - Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof (2011-07-05),

Vaxon Biotech is a biopharmaceutical company focused on developing innovative cancer immunotherapies. Their pipeline includes personalized cancer vaccines and targeted immunotherapies designed to activate the body's immune system to fight cancer. Vaxon Biotech is committed to advancing the field of oncology and improving outcomes for cancer patients through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#531 in Paris

#2,810 in France

Paris, France

Vaxon Biotech